Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy-Reference-Cited by-同舟云学术

Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy

Published:2006-02-01 Issue:3 Volume:106 Page:552-558
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Rohatgi Pooja R.,Swisher Stephen G.,Correa Arlene M.,Wu Tsung T.,Liao Zhongxing,Komaki Ritsuko,Walsh Garrett L.,Vaporciyan Ara A.,Rice David C.,Bresalier Robert S.,Roth Jack A.,Ajani Jaffer A.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference17 articles.

1. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival

2. Esophageal Cancer

3. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

4. Transhiatal Esophagectomy: Clinical Experience and Refinements

5. Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signet Ring Cell Features are Associated with Poor Response to Neoadjuvant Treatment and Dismal Survival in Patients with High-Grade Esophageal Adenocarcinoma;Annals of Surgical Oncology;2021-03-11

2. Evaluation and treatment results of trimodality therapy for advanced esophageal squamous cell carcinoma;Esophagus;2020-09-15

3. Surgically Managed Signet Ring Cell Esophageal Carcinomas in the National Cancer Database;The Annals of Thoracic Surgery;2020-06

4. Comparison of a Concurrent Fluorouracil-Based Regimen and a Taxane-Based Regimen Combined with Radiotherapy in Elderly Patients with Esophageal Squamous Cell Carcinoma;Translational Oncology;2020-03

5. Transcriptional factor regulation network and competitive endogenous RNA (ceRNA) network determining response of esophageal squamous cell carcinomas to neoadjuvant chemoradiotherapy;PeerJ;2019-03-29